Lmr Partners LLP Pfizer Inc Call Options Transaction History

Lmr Partners LLP

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 07, 2024	BUY	$27.7 - $31.39 $7.62 Million - $8.63 Million	275,000 Added 245.97%	386,800 $11.2 Million
Q2 2024 Aug 14, 2024	BUY	$25.26 - $29.6 $2.82 Million - $3.31 Million	111,800 New	111,800 $3.13 Million
Q4 2023 Feb 14, 2024	BUY	$26.13 - $33.94 $5.12 Million - $6.66 Million	196,100 Added 70.31%	475,000 $13.7 Million
Q3 2023 Nov 14, 2023	BUY	$32.09 - $37.51 $5.74 Million - $6.71 Million	178,900 Added 178.9%	278,900 $9.25 Million
Q2 2023 Aug 14, 2023	BUY	$36.12 - $41.79 $3.61 Million - $4.18 Million	100,000 New	100,000 $3.67 Million

3,258

3.62B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $145B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Lmr Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Lmr Partners LLP with notifications on news.